JPY 4192.0
(-2.58%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 12.26 Billion JPY | 8.19% |
2022 | 10.56 Billion JPY | -43.44% |
2021 | 16.38 Billion JPY | -2.49% |
2020 | 20.1 Billion JPY | -29.78% |
2019 | 29.37 Billion JPY | 7.87% |
2018 | 27.19 Billion JPY | -9.52% |
2017 | 29.9 Billion JPY | -8.94% |
2016 | 32.64 Billion JPY | -12.48% |
2015 | 37.39 Billion JPY | 64.91% |
2014 | 23.03 Billion JPY | 26.07% |
2013 | 18.07 Billion JPY | 6.95% |
2012 | 16.92 Billion JPY | -20.17% |
2011 | 17.14 Billion JPY | 4.34% |
2010 | 16.33 Billion JPY | 15.57% |
2009 | 13.97 Billion JPY | 5.24% |
2008 | 12.02 Billion JPY | 5.65% |
2007 | 11.35 Billion JPY | 12.29% |
2006 | 10.5 Billion JPY | 1.92% |
2005 | 10.49 Billion JPY | 6.03% |
2004 | 9.47 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 3.43 Billion JPY | 179.65% |
2023 Q1 | 3.49 Billion JPY | 182.79% |
2023 FY | - JPY | 8.19% |
2023 Q4 | 1.31 Billion JPY | -63.36% |
2023 Q3 | 3.58 Billion JPY | 60.16% |
2023 Q2 | 2.23 Billion JPY | -35.88% |
2022 Q4 | -4.21 Billion JPY | -195.32% |
2022 Q1 | 4.33 Billion JPY | 34.42% |
2022 Q2 | 4.22 Billion JPY | -2.47% |
2022 Q3 | 4.42 Billion JPY | 4.66% |
2022 FY | - JPY | -43.44% |
2021 Q1 | 4.66 Billion JPY | 61.85% |
2021 Q2 | 4.63 Billion JPY | -0.6% |
2021 Q3 | 5.03 Billion JPY | 8.65% |
2021 Q4 | 3.22 Billion JPY | -35.96% |
2021 FY | - JPY | -2.49% |
2020 Q3 | 5.34 Billion JPY | 12.07% |
2020 FY | - JPY | -29.78% |
2020 Q2 | 4.76 Billion JPY | -9.29% |
2020 Q1 | 5.25 Billion JPY | 27.44% |
2020 Q4 | 2.88 Billion JPY | -46.05% |
2019 Q4 | 4.12 Billion JPY | -53.71% |
2019 Q1 | 6.9 Billion JPY | 46.2% |
2019 Q2 | 7.03 Billion JPY | 1.91% |
2019 Q3 | 8.9 Billion JPY | 26.6% |
2019 FY | - JPY | 7.87% |
2018 FY | - JPY | -9.52% |
2018 Q4 | 4.72 Billion JPY | -38.87% |
2018 Q3 | 7.72 Billion JPY | 14.86% |
2018 Q1 | 5.81 Billion JPY | 53.25% |
2018 Q2 | 6.72 Billion JPY | 15.55% |
2017 Q2 | 7.7 Billion JPY | -1.41% |
2017 Q4 | 3.79 Billion JPY | -55.59% |
2017 Q3 | 8.54 Billion JPY | 10.93% |
2017 Q1 | 7.81 Billion JPY | 35.85% |
2017 FY | - JPY | -8.94% |
2016 Q2 | 8.02 Billion JPY | -2.36% |
2016 Q3 | 9 Billion JPY | 12.12% |
2016 Q4 | 5.75 Billion JPY | -36.07% |
2016 FY | - JPY | -12.48% |
2016 Q1 | 8.22 Billion JPY | 50.76% |
2015 Q3 | 11.35 Billion JPY | 23.17% |
2015 Q4 | 5.45 Billion JPY | -51.97% |
2015 FY | - JPY | 64.91% |
2015 Q2 | 9.21 Billion JPY | -1.59% |
2015 Q1 | 9.36 Billion JPY | 138.47% |
2014 Q2 | 4.63 Billion JPY | 14.04% |
2014 Q3 | 7.8 Billion JPY | 68.53% |
2014 Q4 | 3.92 Billion JPY | -49.66% |
2014 FY | - JPY | 26.07% |
2014 Q1 | 4.06 Billion JPY | 3.81% |
2013 Q4 | 3.91 Billion JPY | -11.38% |
2013 FY | - JPY | 6.95% |
2013 Q1 | 3.47 Billion JPY | 44.39% |
2013 Q2 | 3.76 Billion JPY | 8.41% |
2013 Q3 | 4.41 Billion JPY | 17.18% |
2012 Q2 | 5.39 Billion JPY | 12.35% |
2012 FY | - JPY | -20.17% |
2012 Q1 | 4.8 Billion JPY | 86.52% |
2012 Q3 | 1.71 Billion JPY | -68.25% |
2012 Q4 | 2.4 Billion JPY | 40.46% |
2011 Q4 | 2.57 Billion JPY | -55.59% |
2011 Q1 | 5.07 Billion JPY | 75.26% |
2011 Q2 | 5.33 Billion JPY | 5.15% |
2011 Q3 | 5.79 Billion JPY | 8.72% |
2011 FY | - JPY | 4.34% |
2010 Q1 | 5.95 Billion JPY | 232.5% |
2010 Q4 | 2.89 Billion JPY | -56.07% |
2010 Q3 | 6.58 Billion JPY | 35.03% |
2010 Q2 | 4.87 Billion JPY | -18.07% |
2010 FY | - JPY | 15.57% |
2009 Q2 | 4.75 Billion JPY | -1.57% |
2009 Q3 | 6.2 Billion JPY | 30.35% |
2009 Q4 | 1.79 Billion JPY | -71.12% |
2009 FY | - JPY | 5.24% |
2009 Q1 | 4.83 Billion JPY | 249.03% |
2008 Q4 | 1.38 Billion JPY | -75.58% |
2008 FY | - JPY | 5.65% |
2008 Q3 | 5.67 Billion JPY | 36.54% |
2008 Q2 | 4.15 Billion JPY | 0.0% |
2007 FY | - JPY | 12.29% |
2006 FY | - JPY | 1.92% |
2005 FY | - JPY | 6.03% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -103.737% |
Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 98.597% |
Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 104.364% |
Shionogi & Co., Ltd. | 186.7 Billion JPY | 93.43% |
Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -2048.442% |
Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | 66.197% |
Eisai Co., Ltd. | 103.1 Billion JPY | 88.103% |
Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -848.724% |
Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | 33.113% |
Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -36.71% |
Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -234.251% |
Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -774.341% |
Tsumura & Co. | 30.77 Billion JPY | 60.136% |
Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | 34.471% |
Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -132.726% |
Towa Pharmaceutical Co., Ltd. | 35.53 Billion JPY | 65.48% |
Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -78.248% |
Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | 29.989% |
KYORIN Holdings, Inc. | 10.29 Billion JPY | -19.143% |
Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 427.12% |
Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -62.412% |
SymBio Pharmaceuticals Limited | -714 Million JPY | 1818.067% |
MedRx Co., Ltd | -884.51 Million JPY | 1486.86% |
Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -121.574% |
Solasia Pharma K.K. | -635 Million JPY | 2031.811% |
Modalis Therapeutics Corporation | -2.37 Billion JPY | 616.74% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -33.875% |
Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | 66.732% |
Cyfuse Biomedical K.K. | -538.28 Million JPY | 2378.887% |
Toho Holdings Co., Ltd. | 25.84 Billion JPY | 52.536% |
Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -140.452% |